---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-281200"
form_type: "8-K"
ticker: "REVB"
cik: "0001810560"
company_name: "REVELATION BIOSCIENCES, INC."
filed_at: "2026-06-24T20:47:58+00:00"
generated_at: "2026-06-24T20:49:24.775996+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Revelation Biosciences adopts bylaw amendments, authorizes reverse stock split

## Summary
- Board approved amended employment agreements for CEO & CFO: 2x salary+bonus severance on change in control, 18-mo COBRA, 3-year term.
- Stockholders authorized reverse stock split up to 1:250 within one year, allowing Board to fix ratio without further approval.
- Bylaws updated: universal proxy rule compliance, formal 'Cause' definition for officers/directors, removal only for cause due to classified board.
- Elected Jennifer Carver as Class A director to serve until 2029 annual meeting; ratified Baker Tilly as auditor for FY2026.
- Emergency succession framework added for CEO/CFO vacancies: CFO assumes CEO duties, CEO assumes CFO duties pending Board action.

## SEC filing metadata
- accession: 0001193125-26-281200
- form_type: 8-K
- ticker: REVB
- cik: 0001810560
- company_name: REVELATION BIOSCIENCES, INC.
- filed_at: 2026-06-24T20:47:58+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810560/000119312526281200/0001193125-26-281200-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810560/000119312526281200/revb-20260624.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-281200
- JSON: https://secwatch.observer/filing/0001193125-26-281200.json
- Plain text: https://secwatch.observer/filing/0001193125-26-281200.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.